Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Wein currently holds 68,000 shares of Metagenomi, Inc. (MGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Wein has been a net seller of MGX stock. They have purchased $0 and sold $712 worth of shares.
Matthew Wein's most recent insider trade was on Apr 1, 2026, when they sold 68,000 shares at $0.00 per share.
Matthew Wein serves as Executive at Metagenomi, Inc. (MGX). They have executed 7 insider transactions totaling $712 over their tenure at the company.
Matthew Wein holds the position of Executive at Metagenomi, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Matthew Wein has shown a selling trading pattern, with $0 in total purchases and $712 in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew Wein was on Dec 1, 2025, when they purchased $153.6K worth of MGX shares. This transaction involved 96,000 shares at $1.60 per share.
Matthew Wein currently owns 68,000 shares of Metagenomi, Inc. (MGX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Wein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Wein has 7 Form 4 filings on record as an insider at Metagenomi, Inc..
Set alerts for Matthew Wein and 40,000+ other insiders.